DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Tokyo Big Sight

2018 年 11 月 11 日 9:30 上午 - 2018 年 11 月 13 日 5:40 下午

3-11-1 Ariake, Koto-ku, Tokyo, 135-0063 Japan

15th DIA Japan Annual Meeting 2018

Innovative technologies such as AI, big data/genomics, and cell/gene therapies are poised to transform healthcare product development across the globe – join us to discuss these topics.

[V8-S1] Target Product Profile - Better Way to Build Up R&D Management Plan [Call for Abstract Session]

Session Chair(s)

Yoshio  Marumoto, MD, PhD

Yoshio Marumoto, MD, PhD

Associate Professor

Yamaguchi University Hospital, Japan

In this session, general TPP configuration items will be outlined with reference to FDA guidance. Furthermore, from the viewpoint of program management and scope management in the R & D process, we examine how effective TPP should be.

Speaker(s)

Michiko  Ishida, DrSc

Project Management Checklist in AMED

Michiko Ishida, DrSc

Japan Agency for Medical Research and Development (AMED), Japan

Director, Department of Innovative Drug Discovery and Development

Shinobu  Shimizu, PhD

Use of the TPP as a Tool in Academia

Shinobu Shimizu, PhD

Nagoya Univeresity Hospital, Japan

Associate Professor, Department of Advanced Medicine

Atsushi  Tsukamoto, PhD, MSc

General Concept for TPP Utilization in Pharmaceutical Company

Atsushi Tsukamoto, PhD, MSc

Daiichi Sankyo, United States

Head is Therapeutic Area Strategies

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。